Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2025-12-27 @ 5:03 PM
Study NCT ID:
NCT04573192
Status:
RECRUITING
Last Update Posted:
2024-04-08
First Post:
2020-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
Sponsor:
Philogen S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PH-L19TNFCCNU-02/20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None